title: Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
authors.affiliation: From the Population Health Research Institute, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada. eikelbj@mcmaster.
authors.forename: John W
authors.initials: JW
authors.lastname: Eikelboom
authors.affiliation: From the Population Health Research Institute, Department of Medicine, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.
authors.forename: Robert G
authors.initials: RG
authors.lastname: Hart
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000009:adverse effects*; D000069604:Dabigatran; D005260:Female; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D020521:Stroke / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D010975:Platelet Aggregation Inhibitors; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran; D001241:Aspirin
keywords: Editorials; anticoagulants; hemorrhage; warfarin